Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06232317 · ClinicalTrials.gov registry record · NA

Feasibility and Acceptability of ReCognitionVR-based Cognitive Stimulation in Surgical Patients

A NA study of Surgery and Delirium, sponsored by The Methodist Hospital Research Institute.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06232317 is a NA study of Surgery and Delirium that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 30 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06232317, a NA study of Surgery and Delirium, has completed, sponsored by The Methodist Hospital Research Institute.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess the feasibility, acceptability, and safety of using ReCognitionVR virtual reality-based software in older surgical patients. Results from this study will be used to inform the design of a future study in critically ill hospitalized patients at risk for delirium.

Interventions

  • OTHER Virtual Reality Software
  • OTHER Traditional Orientation Methods

Study Locations (1)

Texas

  • Houston Methodist Research Institute - Houston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-12-09
Est. Completion 2024-05-07
Phase NA

What the Registry Record Tells You About NCT06232317

The ClinicalTrials.gov registry entry for NCT06232317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality Software is the first listed.

NCT06232317 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06232317 about?

NCT06232317 is a clinical study titled "Feasibility and Acceptability of ReCognitionVR-based Cognitive Stimulation in Surgical Patients". This study aims to assess the feasibility, acceptability, and safety of using ReCognitionVR virtual reality-based software in older surgical patients. Results from this study will be used to inform the design of a future study in critically ill hospitalized patients at risk for delirium.

What is the current status of trial NCT06232317?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-12-09. Estimated completion is 2024-05-07.

What conditions does trial NCT06232317 study?

This clinical trial studies the following conditions: Surgery, Delirium, Delirium, Post-Operative.

What interventions are being tested in trial NCT06232317?

The interventions under investigation include: Virtual Reality Software (OTHER), Traditional Orientation Methods (OTHER).

Who is sponsoring clinical trial NCT06232317?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06232317 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.